CLC Bio has appointed Richard Lussier as director of business in the Americas region. He joins CLC Bio from RainDance Technologies, where he was vice president of worldwide sales. He has also held positions at Solexa (now Illumina), Fluidigm, Applied Biosystems (now Life Technologies), and Celera Genomics (now Quest Diagnostics).
Stephen Quake has won the $500,000 Lemelson-MIT prize for outstanding innovators for his work in drug discovery, genome analysis, and personalized medicine
Quake has co-founded a number of companies based on technology he has developed in his lab, including Fluidigm, Quantical Pharmaceuticals, and ImmuMetrix. He also helped develop the single-molecule sequencing technology that was commercialized by Helicos BioSciences, and the fetal DNA sequencing techniques commercialized by Verinata Health.
He is a professor of bioengineering and applied physics at Stanford University. He holds a BS and MS in mathematics from Stanford and a PhD in physics from the University of Oxford.